Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Haematology|February 5, 2022
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohortRyan J Stubbins, Maria Stamenkovic, Claudie Roy, et al.
Annals of Hematology|October 5, 2017
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registryBrett L Houston, Jennifer Jayakar, Richard A Wells, et al.
British Journal of Haematology|March 19, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective studyRena Buckstein, Richard A Wells, Nancy Zhu, et al.
Blood|October 24, 2002
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control studyCatherine Metayer, Rochelle E Curtis, Julie Vose, et al.
Bone Marrow Transplantation|September 10, 2005
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host diseaseC L Toze, A Galal, M J Barnett, et al.
British Journal of Haematology|May 30, 2012
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohortCynthia L Toze, Chinmay B Dalal, Thomas J Nevill, et al.
Blood Cell Therapy|September 10, 2025
Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 YearsSatarupa Mohapatra, Yasser R Abou Mourad, Hannah M Cherniawsky, et al.
Haematologica|August 18, 2022
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromesJennifer Teichman, Michelle Geddes, Nancy Zhu, et al.
British Journal of Haematology|May 10, 2018
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximabKatie Y Zhu, Kevin W Song, Joseph M Connors, et al.
British Journal of Haematology|July 6, 2017
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysisHeather A Leitch, Ambica Parmar, Richard A Wells, et al.
Pageof 8